Skip to main content

Table 2 AKR1C3 expression and clinicopathological features in PCa and BPH samples

From: AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

Variables   Cases of PCa BPH
  GS = 6 GS = 7 GS = 8 GS = 9
Age (years) <60 2 2 0 3 3
61-75 6 4 6 4 5
>75 2 4 4 4 3
MOD of AKR1C3 <0.017 4 3 2 2 9
0.017-0.021 5 5 4 2 1
>0.021 1 2 4 6 0
Serum PSA <40 ng/ml 3 5 6 4 10
>40 ng/ml 7 5 4 6 0